IL91843A0 - Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids - Google Patents

Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids

Info

Publication number
IL91843A0
IL91843A0 IL91843A IL9184389A IL91843A0 IL 91843 A0 IL91843 A0 IL 91843A0 IL 91843 A IL91843 A IL 91843A IL 9184389 A IL9184389 A IL 9184389A IL 91843 A0 IL91843 A0 IL 91843A0
Authority
IL
Israel
Prior art keywords
aids
prophylaxis
diagnosis
therapy
peptides useful
Prior art date
Application number
IL91843A
Other languages
English (en)
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of IL91843A0 publication Critical patent/IL91843A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL91843A 1988-10-03 1989-09-29 Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids IL91843A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25294988A 1988-10-03 1988-10-03
US35954389A 1989-06-01 1989-06-01
US40766389A 1989-09-19 1989-09-19

Publications (1)

Publication Number Publication Date
IL91843A0 true IL91843A0 (en) 1990-06-10

Family

ID=27400615

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91843A IL91843A0 (en) 1988-10-03 1989-09-29 Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids

Country Status (10)

Country Link
EP (1) EP0436634A1 (da)
JP (1) JPH04502760A (da)
KR (1) KR900701836A (da)
AU (1) AU640619B2 (da)
DK (1) DK57391A (da)
FI (1) FI911574A0 (da)
IL (1) IL91843A0 (da)
NZ (1) NZ230855A (da)
PT (1) PT91881A (da)
WO (1) WO1990003984A1 (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2627798A (en) * 1951-08-27 1953-02-10 William T Graham Clamp for vibrating shank plows
US2712781A (en) * 1952-03-06 1955-07-12 Glencoe Mfg Company Mounting for earth tiller
US2739518A (en) * 1952-04-19 1956-03-27 Glencoe Mfg Company Shank holder
US2775181A (en) * 1953-08-17 1956-12-25 Int Harvester Co Spring mounted tool shank
US3461971A (en) * 1966-07-05 1969-08-19 American Tractor Equip Corp Vyba mount
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
WO1990015078A1 (en) * 1989-06-05 1990-12-13 Scott Charles F Jr HUMAN MONOCLONAL ANTIBODIES TO HIV-1MN gp 120
EP0448095A1 (en) * 1990-03-21 1991-09-25 Wolf, Hans Joachim, Prof. Dr. Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections
WO1991019011A1 (en) * 1990-06-08 1991-12-12 Repligen Corporation Immunoassays for anti-hiv-1 antibodies
US5712373A (en) * 1990-07-02 1998-01-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute HIV monoclonal antibody specific for the HTLV-IIImn gp120 envelope glycoprotein
JP2989862B2 (ja) * 1990-07-02 1999-12-13 財団法人化学及血清療法研究所 モノクローナル抗体
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047073A1 (en) * 1990-07-19 1992-01-20 William J. Leanza Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047031A1 (en) * 1990-07-19 1992-01-20 Stephen Marburg Peptide-polysaccharide-protein conjugate vaccines
CA2047033A1 (en) * 1990-07-19 1992-01-20 Elizabeth E. Sugg Cyclic hiv principal neutralizing determinant peptides
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
IT1244529B (it) * 1991-01-30 1994-07-15 Ist Superiore Sanita Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1
US6139843A (en) * 1991-04-02 2000-10-31 Albert Einstein College Of Medicine Of Yeshiva University Peptide compositions for the treatment of HIV
JPH05508165A (ja) * 1991-04-02 1993-11-18 アルバート・アインシュタイン・カレッジ・オブ・メディシン・オブ・イェシーバ・ユニバーシティー Ｈｉｖの処置および予防用ワクチン
JPH0570493A (ja) * 1991-05-31 1993-03-23 Chemo Sero Therapeut Res Inst ヒト免疫不全ウイルス（ｈｉｖ）関連免疫調製物
US5558865A (en) * 1991-08-22 1996-09-24 Nissin Shokuhin Kabushiki Kaisha HIV immunotherapeutics
ES2260754T3 (es) 1992-06-18 2006-11-01 Creagen, Inc. Metodo para producir un conjunto de antigenos polipeptidicos combinatorios.
EP0588750A3 (en) * 1992-08-05 1995-01-11 Cigb Process for the production of recombinant polypeptides containing the epitopes of various HIV isolates, their uses as immunogens and for the detection of HIV-specific antibodies.
FR2694938B1 (fr) * 1992-08-10 1996-11-15 Zagury Jean Francois Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant.
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
US5563032A (en) * 1992-10-21 1996-10-08 The United States Of America As Represented By The Department Of Health And Human Services Mosaic polypeptide and methods for detecting the hepatitis E virus
AU6136694A (en) * 1993-02-12 1994-08-29 Repligen Corporation Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same
PT690132E (pt) * 1993-03-11 2004-04-30 Juridical Fou The Chemo Sero T Anticorpo monoclonal anti-hiv
CA2164505A1 (en) 1993-06-07 1994-12-22 Phillip W. Berman Hiv envelope polypeptides
US6913767B1 (en) 1993-10-25 2005-07-05 Genentech, Inc. Compositions for microencapsulation of antigens for use as vaccines
US6080429A (en) * 1993-10-25 2000-06-27 Genentech, Inc. Method for drying microspheres
US5643605A (en) * 1993-10-25 1997-07-01 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
CA2358915C (en) 1998-12-31 2010-06-01 Chiron Corporation Modified hiv env polypeptides
WO2000039304A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
DK1214097T3 (da) * 1999-09-16 2009-11-16 Eisai Corp North America Nukleinsyrer kodende for polyepitop-polypeptider
EP2412242A3 (en) 2001-07-05 2012-06-13 Novartis Vaccines and Diagnostics, Inc. Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
EP1427806A4 (en) 2001-08-31 2006-04-26 Chiron Corp ANTIGENIC HIV-TYPE B POLYPEPTIDE-CODING POLYNUCLEOTIDES, POLYPEPTIDES, AND USES THEREOF
KR100466382B1 (ko) * 2002-01-08 2005-01-14 주식회사 엘지생명과학 인간 면역 결핍 바이러스-1, -2 타입의 단백질이 융합된 재조합 콤보 단백질, 이의 생산방법, 이를 포함하는 벡터, 형질전환된 대장균 및 진단키트

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63501716A (ja) * 1985-10-24 1988-07-14 サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ 合成ペプチドおよびａｉｄｓおよびａｒｃの診断ならびにワクチン注射へのその使用
EP0269712A4 (en) * 1986-06-12 1990-06-26 Biogen Nv PEPTIDES INVOLVED IN THE PATHOGENESIS OF A HIV TYPE INFECTION.
JPH01500432A (ja) * 1986-07-21 1989-02-16 サウスウェスト・ファウンデーション・フォー・バイオメディカル・リサーチ Ａｉｄｓおよびａｒｃのウィルス原因物質に対して免疫化するための組成物および方法
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
EP0366718B1 (en) * 1987-05-29 1995-05-10 Tanox Biosystems, Inc. Monoclonal antibodies neutralizing hiv-1
FR2619012B1 (fr) * 1987-08-07 1989-12-22 Pasteur Institut Vaccins dont l'epitope caracteristique est incorpore dans une proteine de picornavirus, notamment de poliovirus
IL87391A0 (en) * 1987-08-27 1989-01-31 Repligen Corp Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
NL8702403A (nl) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Also Published As

Publication number Publication date
WO1990003984A1 (en) 1990-04-19
DK57391A (da) 1991-05-29
NZ230855A (en) 1994-10-26
FI911574A7 (fi) 1991-04-02
KR900701836A (ko) 1990-12-04
AU4403689A (en) 1990-05-01
JPH04502760A (ja) 1992-05-21
AU640619B2 (en) 1993-09-02
DK57391D0 (da) 1991-04-02
PT91881A (pt) 1990-04-30
FI911574A0 (fi) 1991-04-02
EP0436634A1 (en) 1991-07-17

Similar Documents

Publication Publication Date Title
IL91843A0 (en) Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
GB2221300B (en) Enzyme electrodes and improvements in the manufacture thereof
AU617088B2 (en) Peptides involved in the pathogenesis of hiv infection
AU6399786A (en) Polypeptides used in the diagnosis and therapy of AIDS
NZ224046A (en) Hiv antigenic peptide fragments and their use
GB2213823B (en) Synthetic peptides for use in the diagnosis and prevention of influenza virus infection
ZA886273B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
AU6428890A (en) Therapeutic peptides and proteins
AU1382488A (en) Cyclic peptides and their preparation
NZ224393A (en) Recombinant hiv envelope proteins and uses thereof
IL86796A0 (en) Peptide derivatives,their preparation and their use
ZA888701B (en) Expression of hiv proteins in e.coli and s. cerevisiae
ZA897509B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
AU2738088A (en) Soluble recombinant fce-receptor, the preparation and the use thereof
EG18799A (en) Phenylthioureas, phenylisothioureas and phenylcarbodumides their preparation and use in the control of pests
AU1676288A (en) Human immunodeficiency virus gag-encoded proteins
GR900300003T1 (en) 3-aminodihydrothiophene-2-one peptide derivatives, processes for the preparation and therapeutic use
IL89993A0 (en) Expression of the hiv 24kda gag protein in methylotrophic yeasts
AU4096889A (en) The use of lactam derivatives in the treatment of depression
ZA889506B (en) Soluble recombinant fce-receptor,the preparation and the use thereof
AU6848687A (en) Use of oligopeptides in the treatment of viral infections
IL86983A0 (en) Pyridylthio-,pyridylsulfinyl-and pyridylsulfonyl-phenyl-thioureas,isothioureas and-carbodiimides,their preparation and use in the control of pests
IE891349L (en) EXPRESSION OF THE HIV kDa GAG PROTEIN IN YEAST
AU8260287A (en) N-phenyl-N-carboxythioureas and their use in the control of pests
SG130694G (en) Peptide fragments of hiv and their use in vaccines and diagnosis